Brief: Brooklyn ImmunoTherapeutics Announces Changes To Executive Management

Ernexa Therapeutics

31/05/2022 12:48

May 31 (Reuters) - Brooklyn Immunotherapeutics Inc  BTX.O :
    * BROOKLYN IMMUNOTHERAPEUTICS ANNOUNCES CHANGES TO EXECUTIVE
MANAGEMENT: MATT ANGEL, PH.D. APPOINTED INTERIM CHIEF EXECUTIVE
OFFICER AND PRESIDENT, ANDREW JACKSON APPOINTED CHIEF FINANCIAL
OFFICER POSTPONES 2022 ANNUAL MEETING

Source text for Eikon:  ID:nGNX7XBnDY 
Further company coverage:  BTX.O